The current status and future applications of interleukin 2- and adoptive immunotherapy in cancer treatment.
Simpson
C
C
Seipp
C A
CA
Rosenberg
S A
SA
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000627:therapeutic use* / Q000633:toxicity; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use*
D007376:Interleukin-2; D011994:Recombinant Proteins